Benzinga | Oct 28, 2021 05:09AM EDT

SVB Leerink Maintains Outperform on Teladoc Health, Lowers Price Target to $205

SVB Leerink analyst Stephanie Davis maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target from $218 to $205.